Abstract

Tumor dormancy, a state of tumor, is clinically undetectable and the outgrowth of dormant tumor cells into overt metastases is responsible for cancer-associated deaths. However, the dormancy-related molecular mechanism has not been clearly described. Some researchers have proposed that cancer stem cells (CSCs) and disseminated tumor cells (DTCs) can be seen as progenitor cells of tumor dormancy, both of which can remain dormant in a non-permissive soil/niche. Nowadays, research interest in the cancer biology field is skyrocketing as mesenchymal stem cells (MSCs) are capable of regulating tumor dormancy, which will provide a unique therapeutic window to cure cancer. Although the influence of MSCs on tumor dormancy has been investigated in previous studies, there is no thorough review on the relationship between MSCs and tumor dormancy. In this paper, the root of tumor dormancy is analyzed and dormancy-related molecular mechanisms are summarized. With an emphasis on the role of the MSCs during tumor dormancy, new therapeutic strategies to prevent metastatic disease are proposed, whose clinical application potentials are discussed, and some challenges and prospects of the studies of tumor dormancy are also described.

Highlights

  • Clinical treatments are developing, cancer is still a significant challenge due to recurrence and metastasis

  • This review summarizes the mechanisms of mesenchymal stem cells (MSCs)-mediated modulation of tumor dormancy and discusses the relationship between cancer stem cells and dormant tumor cells

  • We mainly focus on the role of bone marrow-derived MSCs (BMSCs) from bone marrow on tumor dormancy

Read more

Summary

Introduction

Clinical treatments are developing, cancer is still a significant challenge due to recurrence and metastasis. Inhibit tumor cell growth and drive CSCs into dormancy by mediating the expression of N-myc downstream-regulated gene 1 (NDRG1) and activating p38 MAPK and p21 (1).Inducing BMSCs to migrate to cancer site (2).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.